US President Joe Biden is set to announce a new set of guidelines this week that aim to protect the reproductive rights of women in the country. The announcement follows the overturning of the landmark Roe v. Wade ruling by the Supreme Court early this year.
Biden will announce the new guidelines and grants Tuesday that aim to protect reproductive rights during a meeting of the reproductive rights task force that will also be attended by Vice President Kamala Harris.
The US leader is also set to describe how abortion rights have been curtailed since the Conservative-majority Supreme Court overturned the 1973 ruling guaranteeing a woman’s right to have an abortion.
The meeting would mark 100 days since the high court overturned the ruling and will focus on how millions of women in the country are no longer allowed to access abortion services and how doctors and nurses are facing criminal penalties for providing such services, according to a White House official and a letter to Biden from Jen Klein, the head of the inter-agency task force on abortion access.
During the meeting, Biden is also set to talk about new guidelines for universities from the Education Department to protect students from discrimination on the basis of pregnancy and $6 million in new grants to protect access to reproductive healthcare from the Health and Human Services Department.
According to Klein’s letter, abortion bans have come into effect in over a dozen states since the Supreme Court overturned Roe v. Wade. Almost 30 million women of reproductive age are living in the state with an abortion ban in place, including 22 million women who cannot access abortion services after six weeks.
The letter by Klein also cited GOP Senator Lindsey Graham’s plan to introduce a national abortion ban.
Physicians and abortion rights advocates have now urged the Food and Drug Administration to get Danco Laboratories to seek the approval of mifepristone, a pill that is used in terminating early pregnancies at home for miscarriage management.
Danco, which is one of the two companies that make the pill, said it has no current plans to do so but will consider it in the future.


Trump Attends Dover Ceremony Honoring U.S. Personnel Killed in Syria
Trump Signals Progress in Ukraine Peace Talks Ahead of U.S.–Russia Meeting
Italy Supreme Court Upholds Salvini Acquittal in Migrant Kidnapping Case
U.S.-Russia Talks in Miami Raise Hopes for Potential Ukraine War Deal
U.S. and China Push for Ceasefire as Thailand–Cambodia Border Clashes Escalate
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
Syria, Kurds and U.S. Race to Show Progress on SDF Integration Deal
UN Warns Gaza Humanitarian Aid at Risk as Israel Registration Rules Threaten NGO Operations
Trump Administration Plans Major Increase in Denaturalization Cases for Naturalized U.S. Citizens
Trump Administration Proposes Sweeping Limits on Gender-Affirming Care for Children
Putin Signals Possible Peace or Continued War in Ukraine at Major Year-End Address
Dan Bongino to Step Down as FBI Deputy Director After Brief, Controversial Tenure
U.S. Senators Move Toward Deal to Strengthen Military Helicopter Safety Rules
Canada Signals Delay in US Tariff Deal as Talks Shift to USMCA Review
Trump Signs Order to Ease Federal Marijuana Rules, Signaling Major Policy Shift
Honduras Election Recount Delayed Amid Protests and Political Tensions
Trump Expands U.S. Travel Ban to Antigua and Barbuda, Dominica, Sparking Economic Fears in the Caribbean 



